What if the long term plan was to reverse merge twice?

New Post Public Reply Private Reply Replies (2) Message Board
DTL
What if the long term plan was to reverse merge twice? What if the long term plan was not a 2.5B AS and 1.7 OS but a much lower share structure? What if GRCU was created solely for test marketing the many quality products we all seemed to like using public company GRCU in a brand new sector? What if GRCU is simply a guinea pig? The Rico Suave licensing was turned over to Green Cures Inc. so what is Green Cures Inc doing with it after so much work was done on that product? Maybe private company Green Cures Inc. is selling it for big money to a large energy drink company? The product logo, the Spanish market sector and branding and licensing are complete! IMO it doesn't take years of test marketing to show a percentage of individual products sold over a percentage of time. Maybe it just takes a year or so! I'm confident a Rico Suave business plan, product and marketing report could be produced and sold to a large energy drink company. That value added to Green Cures Inc is merged with GRCU!
What if GRCU is purposely being turned into a shell company and Green Cures Inc will R/M into the GRCU shell. What if the plan was always having a PPS at approx. .0001 just like TTDZ's was .0001. This 2nd R/M might also have added benefits of losing some TTDZ baggage albeit unknown to me what that baggage would be.
GRCU recently needed to pay $30K in taxes against what sales? Were those taxes TTDZ liabilities that can be eliminated through another public merger? Did management have a plan for this all along? Maybe the long term plan has always been a new share structure, new valuations, possible new ticker, etc. Were figure head CEO's brought in on purpose as temporary place holders? Costs have been kept to absolute minimum while not paying high executive salaries but only some shares based on time served. Nobody including Cruz has become rich so far but just the opposite so this is not your typical share selling scam company. The AS hasn't been touched and all signs point to much needed capitol so what is the plan for that capitol if not to sell shares? Maybe the last piece to the grand plan will answer that! Was Jones brought in for a purposeful short term assignment so he could inspect what was going on before providing "the 2nd newly formed" public company his higher quality CBD products? Are new company labels being created now with the new company logo's? IMO this would all be legal and a very clever strategy. It would be like using first company GRCU as a guinea pig while products come and go, bashers have their fun, management learns much in a new industry, etc. Then a much healthier and higher valued second company is created and emerges poised to do the major marketing, advertising and new product releases based on a one year study. GRCU has acted as a squeaky clean pink sheet filer. They terminated a lawyer with a checkered reputation very quickly. They want to be seen as legitimate and follow all the rules but for what? To empty their shelves and fold shop? That makes zero sense to me! It won't surprise if that is the case since anything can happen in the OTC but my gut tells me the plan is otherwise.
I've said this before; Cruz is either very clever or a complete idiot. I look to his success in real estate and his association with David O. who has developed some quality hemp based products. I look at the other board members that Cruz is affiliated with and none of these traits spell stupidity! These are very sharp individuals. Sure some of the idiots on Ihub who are bitter over losses might want to call them idiots but in my opinion it's "the copper calling the kettle black". Cruz must know what marketing is because real estate sales are based on advertising and marketing in a very big way. I want to think that Cruz knows exactly what he is doing albeit very frustrating until it all unfolds. Time will tell but all the above is what makes the most sense to me.

Green Cures & Botanical Distribution Inc. (GRCU) Stock Research Links

GRCU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 394

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
DKSH's Vietnam Oncology Pact Carries Real Promise, Risk

Updated Category News Views 58

A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 459

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 83

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 140

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 661

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 570

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 318

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Luca's Campo Morado Denial Makes Guerrero Risk Clear

Updated Category News Views 19

A Dangerous Headline Needs More Than a Quick Rebuttal One ugly allegation can do more damage to a junior miner than a lousy quarter, especially when it involves a mine in Guerrero State and alleged criminal control. Luca Mining has flatly rejected Mexican media reports claiming that its Campo Morado Mine is controlled by a criminal organization. The company says the...

Continue Reading

Top 5 Most Recently Viewed Articles

Leidos' Autonomous Vessels Chart Bold Naval Waters

Updated Category News Views 49

Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...

Continue Reading
89bio to Showcase Pegozafermin Trial Insights at Major Conference

Updated Category News Views 67

89bio Presents Key Findings from ENLIVEN Phase 2b Trial 89bio, Inc. (NASDAQ: ETNB), a biopharmaceutical company committed to developing innovative treatments for liver and cardiometabolic diseases, has exciting news. The company will present new analyses from its Phase 2b ENLIVEN trial, which assesses the efficacy of pegozafermin in patients suffering from metabolic...

Continue Reading
New Insights on Penetrium's Role in Combating TNBC Growth

Updated Category News Views 487

Hyundai ADM Bio Unveils Promising Results for Penetrium – Groundbreaking treatment strategy targets both primary and metastatic tumors. Hyundai ADM Bio has announced significant findings related to its pioneering agent, Penetrium, which exhibited impressive anti-metastatic properties in recent preclinical studies involving triple-negative breast cancer (TNBC). This...

Continue Reading
Designer Brands Inc. Reveals Upcoming Earnings Call for Q1 2025

Updated Category News Views 178

Upcoming Earnings Release for Designer Brands Inc. Designer Brands Inc. (NYSE: DBI), a leading force in footwear and accessories, has announced an important date for shareholders and interested parties alike. The company is set to release its earnings for the first quarter of 2025 on June 10, 2025. This marks a significant event, as it gives insights into the company's...

Continue Reading
Harvard Bioscience, Inc. Reports Q1 2025 Financial Performance

Updated Category News Views 374

Strong Financial Insights from Harvard Bioscience Harvard Bioscience, Inc. (NASDAQ: HBIO) recently shared its financial results for the first quarter, showcasing a mixed performance influenced by various market factors. The company expressed confidence in its revenue management and highlighted new product developments that are energizing its business strategies. Revenue...

Continue Reading